|
Issue |
Title |
|
Vol 15, No 3 (2022) |
Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation |
Abstract
PDF (Rus)
|
N. A. Avxentyev, Yu. V. Makarova |
|
Vol 14, No 4 (2021) |
Machine learning based on laboratory data for disease prediction |
Abstract
PDF (Rus)
|
A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev |
|
Vol 8, No 2 (2015) |
MAGNESIUM DEFICIENCY OF PATIENTS WITH HORMONE DEPENDENT DISEASES: PHARMACOEPIDEMIOLOGICAL PROFILE AND LIFE QUALITY ASSESSMENT |
Abstract
PDF (Rus)
|
Dmitry Vladislavovich Blinov, Juliana Vladimirovna Zimovina, Elena Anatol'evna Sandakova, Tat'yana Igorevna Ushakova |
|
Vol 9, No 2 (2016) |
MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE |
Abstract
PDF (Rus)
|
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya |
|
Vol 7, No 2 (2014) |
MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY |
Abstract
PDF (Rus)
|
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava |
|
Vol 9, No 1 (2016) |
MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 |
Abstract
PDF (Rus)
|
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum |
|
Vol 17, No 2 (2024) |
Mathematical modeling and analysis of export trends for certain pharmaceutical groups |
Abstract
PDF (Rus)
|
А. R. Shaikhislamova, N. А. Gasratova |
|
Vol 11, No 1 (2018) |
Medical care of ambulatory patients and its assessment: a review of international experience |
Abstract
PDF (Rus)
|
D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky |
|
Vol 14, No 2 (2021) |
Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region |
Abstract
PDF (Rus)
|
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin |
|
Vol 15, No 4 (2022) |
Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction |
Abstract
PDF (Rus)
|
D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko |
|
Vol 5, No 2 (2012) |
MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS |
Abstract
PDF (Rus)
|
Yu. V. Miroshnichenko, V. S. Gaynov |
|
Vol 13, No 4 (2020) |
Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard |
Abstract
PDF (Rus)
|
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova |
|
Vol 9, No 2 (2016) |
METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY |
Abstract
PDF (Rus)
|
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov |
|
Vol 9, No 3 (2016) |
METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL |
Abstract
PDF (Rus)
|
O. V. Zhukova, S. V. Kononova |
|
Vol 16, No 2 (2023) |
Methodological approach to the formation of the list of high-tech medical care types |
Abstract
PDF (Rus)
|
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy |
|
Vol 6, No 3 (2013) |
METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES |
Abstract
|
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze |
|
Vol 5, No 2 (2012) |
METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
Abstract
|
R. I. Yagudina, I. V. Sorokovikov |
|
Vol 17, No 2 (2024) |
Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access |
Abstract
PDF (Rus)
|
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy |
|
Vol 11, No 1 (2018) |
Methods of clinical assessment from the “Clinical Recommendations” resource of the Ministry of Healthcare of Russia: a systematic review |
Abstract
PDF (Rus)
|
V. M. Vatolin, O. A. Sukhorukikh, Zh. A. Galeeva, D. V. Lukyantseva, O. O. Buzuverova, O. V. Kirsanova, E. M. Murtazina, D. G. Ilyukhin, L. S. Shubina |
|
Vol 7, No 3 (2014) |
MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN |
Abstract
PDF (Rus)
|
V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan |
|
Vol 7, No 4 (2014) |
MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES |
Abstract
PDF (Rus)
|
M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya |
|
Vol 11, No 1 (2018) |
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics |
Abstract
PDF (Rus)
|
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko |
|
Vol 11, No 4 (2018) |
Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease |
Abstract
PDF (Rus)
|
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev |
|
Vol 14, No 3 (2021) |
Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping |
Abstract
PDF (Rus)
|
I. V. Sarvilina, O. A. Shavlovskaya, O. A. Gromova, A. V. Naumov, M. N. Sharov, Yu. S. Prokofyeva |
|
Vol 16, No 1 (2023) |
Modern biomarkers of acute kidney injury |
Abstract
PDF (Rus)
|
D. I. Korabelnikov, M. O. Magomedaliev |
|
Vol 5, No 1 (2012) |
MODERNIZATION OF THE MEDICAL SERVICES MARKET |
Abstract
|
A. U. Kulikov |
|
Vol 16, No 2 (2023) |
Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions |
Abstract
PDF (Rus)
|
O. A. Gromova, I. Yu. Torshin |
|
Vol 9, No 3 (2016) |
MONITORING OF CONSUMER ATTITUDES TO MEDICINES |
Abstract
PDF (Rus)
|
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka |
|
Vol 16, No 4 (2023) |
Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders |
Abstract
PDF (Rus)
|
O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova |
|
Vol 12, No 2 (2019) |
New framework for the development of clinical guidelines in Russia |
Abstract
PDF (Rus)
Приложение (Rus)
|
D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov |
|
Vol 16, No 2 (2023) |
New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma |
Abstract
PDF (Rus)
|
M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina |
|
Vol 8, No 3 (2015) |
NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
Abstract
PDF (Rus)
|
D. V. Blinov |
|
Vol 16, No 1 (2023) |
Non-invasive respiratory support in patients with severe community-acquired pneumonia |
Abstract
PDF (Rus)
|
S. V. Korotchenko, D. I. Korabelnikov |
|
Vol 11, No 3 (2018) |
Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review |
Abstract
PDF (Rus)
|
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin |
|
Vol 16, No 4 (2023) |
Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen |
Abstract
PDF (Rus)
|
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova |
|
Vol 12, No 4 (2019) |
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation |
Abstract
PDF (Rus)
|
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev |
|
Vol 11, No 1 (2018) |
Options to optimize the access to biosimilars: analysis and solutions |
Abstract
PDF (Rus)
|
O. V. Kirsanova, V. V. Omelyanovsky |
|
Vol 8, No 3 (2015) |
ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION |
Abstract
PDF (Rus)
|
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova |
|
Vol 11, No 4 (2018) |
Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense |
Abstract
PDF (Rus)
|
D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy |
|
Vol 14, No 2 (2021) |
Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting |
Abstract
PDF (Rus)
|
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov |
|
Vol 12, No 2 (2019) |
Organizational structure and funding of health technology assessment agencies around the world |
Abstract
PDF (Rus)
|
G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak |
|
Online First |
Osteoarthritis therapy misconcepts |
Abstract
PDF (Rus)
|
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov |
|
Vol 12, No 3 (2019) |
Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens |
Abstract
PDF (Rus)
|
D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko |
|
Vol 13, No 3 (2020) |
Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 |
Abstract
PDF (Rus)
|
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina |
|
Vol 7, No 2 (2014) |
PARAMETERS OF HEALTH CARE SYSTEMS |
Abstract
PDF (Rus)
|
V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov |
|
Vol 11, No 4 (2018) |
Patient registers and account registries of compulsory medical insurance: integration and replaceability |
Abstract
PDF (Rus)
|
I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich |
|
Vol 7, No 1 (2014) |
PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY |
Abstract
PDF (Rus)
|
D. V. Blinov |
|
Vol 8, No 1 (2015) |
PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION |
Abstract
PDF (Rus)
|
L. S. Melnikova |
|
Vol 14, No 3 (2021) |
Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines |
Abstract
PDF (Rus)
|
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva |
|
Vol 16, No 4 (2023) |
Peculiarities of real-world data application for health technology assessment in Asian countries |
Abstract
PDF (Rus)
|
B. B. Kondratyeva, F. V. Gorkavenko, V. V. Omelyanovskiy |
|
251 - 300 of 518 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |